Nasdaq· X-Ray Apparatus & Tubes & Related Irradiation Apparatus· Inc. DE· CIK 0000859737

HOLX

HOLOGIC INC
—
12-mo target$76.67 (+0.9%)
High Impact Filing (7/10)50 Institutional Exits Healthcare & Medical Devices
Snapshot
The big-picture read on HOLX right now — valuation, ownership and activity at a glance.
Inst. Holders
1 funds
Inst. Activity
0 buys / 50 sells
SEC Reports
5
Congressional
2 trades
Price chart
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Jul 28, 2026 earnings_calendar
HOLX Q3 2026 Earnings After Market Close — 2026-07-28
Jun 30, 2026 Inst.
HUNTINGTON NATIONAL BANK — NEAR_EXIT
1 shares (—)
Jun 30, 2026 Inst.
CITADEL ADVISORS LLC — EXIT
0 shares ($0.00)
Apr 17, 2026 SEC
Hologic, Inc. has filed Form 15-12G to terminate its SEC registration and suspend reporting obligations, effective April
15-12G — Impact 7/10
Apr 13, 2026 SEC
Hologic Inc. has two shelf registration statements (File Nos. 333-73596 and 033-65019) that became effective on April 10
EFFECT — Impact 3/10
Apr 8, 2026 Congress
Laura Friedman exchange
$1,001 - $15,000 — House
Apr 8, 2026 Congress
Laura Friedman sell
$1,001 - $15,000 — House
Apr 7, 2026 SEC
Hologic completed its acquisition by Blackstone and TPG, becoming a private company. The deal closed at $76 per share in
8-K — Impact 9/10
Analyst ratings buy % -100.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Recent analyst actions
DateFirmActionRatingFirm rating
Jan 12, 2026Argus ResearchDOWNGRADEHold 54%
Jan 5, 2026Evercore ISI GroupDOWNGRADEIn-Line 59%
Nov 11, 2025Morgan StanleyMAINTAINEqual-Weight 55%
Oct 23, 2025MizuhoDOWNGRADENeutral 52%
Oct 22, 2025Raymond JamesDOWNGRADEMarket Perform 54%
Oct 22, 2025Stephens & Co.DOWNGRADEEqual-Weight 54%
Oct 22, 2025JP MorganDOWNGRADENeutral 55%
Oct 21, 2025Leerink PartnersMAINTAINMarket Perform 49%
Oct 21, 2025BTIGREITERATENeutral 53%
Oct 21, 2025NeedhamREITERATEHold 50%
Monthly consensus history
PeriodStr. BuyBuyHoldSellStr. SellBuy %Distribution
Aug 1, 20260020120%
Jul 1, 20260020120%
Jun 1, 20260020120%
May 1, 20260020120%
Apr 1, 20260020120%
Mar 1, 20260020120%
Feb 1, 20260020120%
Jan 1, 202634180028%
Price targets
Where 9 covering analysts think HOLX trades over the next 12 months.
$76.67 +0.9% upside Hold
Current$76.01 Low$76.00 Median$76.00 High$78.00 9 analysts
$76.00$78.00
Analyst rating Hold· 3.0/5 as of Jun 3, 2026
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
5 SEC filing reports analyzed · 0 bullish, 0 bearish, 1 mixed, 4 neutral · avg impact 6.4/10.
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Jul 28, 2026
earnings_calendar
HOLX Q3 2026 Earnings After Market Close — 2026-07-28
Apr 30, 2026
earnings_calendar
HOLX Q2 2026 Earnings After Market Close — 2026-04-30
Apr 6, 2026
dark_pool
Dark Pool: HOLX — 19.1M shares, 33,807 trades
Week starting 2026-04-06. Total ATS volume: 19,125,714 shares across 33,807 trades.
Apr 2, 2026
short_volume
Short Volume: HOLX — 56.6% short (0.3M / 0.6M)
Short: 319,144 | Exempt: 0 | TRF Vol: 564,124 | Short Ratio: 56.6% | Off-exchange volume (dark pool + OTC)
Mar 30, 2026
dark_pool
Dark Pool: HOLX — 2.0M shares, 29,680 trades
Week starting 2026-03-30. Total ATS volume: 1,964,629 shares across 29,680 trades.
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
PeriodEPS Est.RangeGrowth30d RevUp/DnRevenue#
Next FY$3.78$3.05–$4.3915.4%+0.0%0↑ 5↓$4.5B7
Current FY$4.46$4.35–$4.644.6%+0.8%0↑ 8↓$4.2B15
Current Q$1.07$1.01–$1.143.8%+1.4%0↑ 4↓$1.0B12
Next Q$1.12$1.09–$1.184.0%+1.3%1↑ 3↓$1.1B10
Current-quarter EPS estimate — revision history
WhenEPS estimateChange vs now
Current$1.069—
7d ago$1.054+0.015
30d ago$1.054+0.015
60d ago$1.061+0.008
90d ago$1.099-0.029
Institutional ownership
Which big funds own HOLX (from quarterly 13F filings) and who is adding or trimming.
1 institutional holders with $0.00 total value (1 shares) as of 2026-Q2. Top holders: HUNTINGTON. Net selling activity: 50 institutions trimmed/exited vs 0 added.
Top holders — 2026-Q2
FundSharesValue% TrackedLast move
HUNTINGTON NATIONAL BANK1$0.00—%NEAR_EXIT -99.8%
Recent position changes
FundActionPrevCurrentChangeValue
HUNTINGTON NATIONAL BANKNEAR_EXIT4051-99.8%—
CITADEL ADVISORS LLCEXIT1,090,6600-100.0%$0.00
AmundiEXIT1,469,1960-100.0%$0.00
GEODE CAPITAL MANAGEMENT, LLCEXIT6,058,8450-100.0%$0.00
JPMORGAN CHASE & COEXIT821,1570-100.0%$0.00
DIMENSIONAL FUND ADVISORS LPEXIT357,9110-100.0%$0.00
BANK OF MONTREAL /CAN/EXIT261,2280-100.0%$0.00
FMR LLCEXIT604,6060-100.0%$0.00
MORGAN STANLEYEXIT3,573,0110-100.0%$0.00
BANK OF AMERICA CORP /DE/EXIT2,254,0240-100.0%$0.00
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
15 insiders, 50 transactions. Net $0.00 — $0.00 bought, $0.00 sold.
DateInsiderTitleTypeSharesPriceValue
Apr 7, 2026COHN BENJAMIN JORDANPrincipal Accounting OfficerD3,505——
Apr 7, 2026COHN BENJAMIN JORDANPrincipal Accounting OfficerD3,382——
Apr 7, 2026COHN BENJAMIN JORDANPrincipal Accounting OfficerD7,132——
Apr 7, 2026COHN BENJAMIN JORDANPrincipal Accounting OfficerD7,505——
Apr 7, 2026Dockendorff Charles JDirectorD5,535——
Apr 7, 2026Dockendorff Charles JDirectorD4,536——
Apr 7, 2026Dockendorff Charles JDirectorD4,210——
Apr 7, 2026Dockendorff Charles JDirectorD5,293——
Apr 7, 2026Dockendorff Charles JDirectorD5,055——
Apr 7, 2026Dockendorff Charles JDirectorD7,322——
Congressional trades
HOLX trades disclosed by members of Congress, with disclosure delay.
1 members · 0 buys / 1 sells
DateMemberPartyChamberTypeAmountAssetDisclosed
Apr 8, 2026Laura FriedmanDHOUSEEXCHANGE$1,001 - $15,000Hologic IncMay 15, 2026(38d)
Apr 8, 2026Laura FriedmanDHOUSESELL$1,001 - $15,000Hologic IncMay 15, 2026(38d)
All HOLX filing & press-release reports (5)